Combination of Nanovectorized siRNA Directed against Survivin with Doxorubicin for Efficient Anti-Cancer Activity in HER2+ Breast Cancer Cells

According to Globocan 2020, breast cancer is considered one of the most common cancers affecting women and is one of the leading causes of death in over 100 countries. The available classical treatment options do not always give satisfactory outcomes, and some patients develop resistance to these tr...

Descripción completa

Detalles Bibliográficos
Autores principales: Eljack, Sahar, Allard-Vannier, Emilie, Misericordia, Yoann, Hervé-Aubert, Katel, Aubrey, Nicolas, Chourpa, Igor, Faggad, Areeg, David, Stephanie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9696063/
https://www.ncbi.nlm.nih.gov/pubmed/36432729
http://dx.doi.org/10.3390/pharmaceutics14112537

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9696063/
https://www.ncbi.nlm.nih.gov/pubmed/36432729
http://dx.doi.org/10.3390/pharmaceutics14112537

Ejemplares similares